IJsselstein (Netherlands)/ Hyderabad Aug 12 (ANI/Business Wire India): Isogen Biosolutions B. V. has rebranded itself as Ocimum Biosolutions B. V. The aim of the rebranding exercise is to tap the emerging opportunities and need for globalized solutions in Genomics.
This represents a significant milestone in company's history as the company hones its position as the premier integrated global genomics solutions provider.
Synthetic DNA oligonucleotides now have wide spectrum of applications ranging from being used in fundamental research, as diagnostic reagents to discovery of pharmaceutical compounds.
The organization derives its name from Ocimum sanctum, which is considered to be an allude to purity. The value it brings to the medical world captures the essence of all genomes and species, which has made so much of a difference to the post-genomic era. Ocimum provides quality solutions spanning across the genomics space and partners with global organizations in the pursuit of improved and affordable healthcare.
"We now partner with global organizations and groups in their discovery endeavors from as early as basic research all the way up to clinical validations and target discovery. This announcement signifies our wide repertoire of offerings in genomics space. This makes it an integral part of our genomics business model," says Anuradha Acharya, CEO of Ocimum Biosolutions.
Ludwig Winzer, Managing Director, Isogen Biosolutions B.V., said "With this re-branded image, we would like to communicate the wide range of benefits and solutions we now offer to the large scientific community, who over the years have known and trusted Isogen Biosolutions for their DNA oligonucleotide needs."
Ashwin Sivakumar, Ph.D., Director of Marketing and Outreach, said "With Brand Ocimum and the recent acquisition of Gene Logic's Genomic division, we now present more than a decade of experience in the genomics space. We would also like to announce the launch of our new dedicated QUTE T oligonucleotide website and ordering portal."